Information
11 Sinchon 2-ro, Paju-si, Gyeonggi-do, South Korea
+82 31-945-8190
-
-
Overview
- Summary
- Sejong Medical is a specialized medical device manufacturer established in 1996, recognized as a leader in laparoscopic surgical instruments in South Korea. The company focuses on developing and supplying high-quality, high-functionality medical devices for laparoscopic surgery, striving for continuous innovation to satisfy both patients and medical professionals. It has played a significant role in replacing imported laparoscopic surgical instruments with domestically produced ones in the Korean market. The company is actively expanding its global business to establish itself as a world-leading laparoscopic medical device enterprise.Sejong Medical is a specialized medical device manufacturer established in 1996, recognized as a leader in laparoscopic surgical instruments in South Korea. The company focuses on developing and supplying high-quality, high-functionality medical devices for laparoscopic surgery, striving for continuous innovation to satisfy both patients and medical professionals. It has played a significant role in replacing imported laparoscopic surgical instruments with domestically produced ones in the Korean market. The company is actively expanding its global business to establish itself as a world-leading laparoscopic medical device enterprise.
- Key Products/Technologies
- Sejong Medical's main product lines include laparoscopic surgery systems and equipment, offering a diverse range of products such as Trocar, Single Port, Specimen Pouch, Suture Loop, Suction Irrigation, Smoke Filter, and BUMI. The Trocar, in particular, serves as a crucial channel for laparoscopic surgical instruments to enter and exit the body, maintaining abdominal pressure during surgery. The Single Port for single-incision surgery allows for flexible instrument use through a single incision, providing excellent flexibility and heat resistance suitable for robotic surgery environments. The Lap-iX suction and irrigation device is a laparoscopic surgical instrument that combines suction and irrigation functions with an electrode for incision and hemostasis. This new product boasts higher profitability compared to existing ones and has received special 510K approval from the US FDA, demonstrating its technological prowess. The company operates a 100% in-house production system to manufacture flawless laparoscopic medical devices, ensuring customer satisfaction through stringent quality control.Sejong Medical's main product lines include laparoscopic surgery systems and equipment, offering a diverse range of products such as Trocar, Single Port, Specimen Pouch, Suture Loop, Suction Irrigation, Smoke Filter, and BUMI. The Trocar, in particular, serves as a crucial channel for laparoscopic surgical instruments to enter and exit the body, maintaining abdominal pressure during surgery. The Single Port for single-incision surgery allows for flexible instrument use through a single incision, providing excellent flexibility and heat resistance suitable for robotic surgery environments. The Lap-iX suction and irrigation device is a laparoscopic surgical instrument that combines suction and irrigation functions with an electrode for incision and hemostasis. This new product boasts higher profitability compared to existing ones and has received special 510K approval from the US FDA, demonstrating its technological prowess. The company operates a 100% in-house production system to manufacture flawless laparoscopic medical devices, ensuring customer satisfaction through stringent quality control.
- Continuous research and development through its medical engineering laboratory form the foundation of its core technological capabilities. The company invests over 4% of its revenue in R&D, strengthening its position as a specialized medical device company. Efforts in developing and commercializing robotic surgical instruments, including successful development of robotic surgical trocars, demonstrate its proactive response to future medical technology trends. The development of dedicated trocars for bioelectronic medicines is expected to open new avenues for medical device treatments, securing future growth momentum.Continuous research and development through its medical engineering laboratory form the foundation of its core technological capabilities. The company invests over 4% of its revenue in R&D, strengthening its position as a specialized medical device company. Efforts in developing and commercializing robotic surgical instruments, including successful development of robotic surgical trocars, demonstrate its proactive response to future medical technology trends. The development of dedicated trocars for bioelectronic medicines is expected to open new avenues for medical device treatments, securing future growth momentum.
- Core Advantages
- A pioneering company in the localization of laparoscopic surgical instruments in Korea, successfully developing the first domestic laparoscopic trocar. This achievement significantly contributed to reducing Korea's reliance on imported medical devices in a market previously dominated by foreign products for over 30 years.A pioneering company in the localization of laparoscopic surgical instruments in Korea, successfully developing the first domestic laparoscopic trocar. This achievement significantly contributed to reducing Korea's reliance on imported medical devices in a market previously dominated by foreign products for over 30 years.
- Possession of a diverse and extensive portfolio of laparoscopic surgical instruments. The wide range of products, including disposable endoscopic trocars, biopsy tools, single-port surgical instruments, and dedicated ports for robotic surgery, enables the company to meet various surgical environments and medical professional needs. The company holds an estimated 90% domestic market share for laparoscopic specimen pouches, indicating strong market dominance.Possession of a diverse and extensive portfolio of laparoscopic surgical instruments. The wide range of products, including disposable endoscopic trocars, biopsy tools, single-port surgical instruments, and dedicated ports for robotic surgery, enables the company to meet various surgical environments and medical professional needs. The company holds an estimated 90% domestic market share for laparoscopic specimen pouches, indicating strong market dominance.
- Strong global competitiveness and an established extensive export network. Acquisition of major international quality certifications such as US FDA and European CE, securing product reliability and a foundation for international market entry. An expanding global presence through partnerships and sales networks in over 30 countries worldwide.Strong global competitiveness and an established extensive export network. Acquisition of major international quality certifications such as US FDA and European CE, securing product reliability and a foundation for international market entry. An expanding global presence through partnerships and sales networks in over 30 countries worldwide.
- Operation of a 100% in-house production system and a rigorous quality control framework. The company adheres to a principle of producing flawless medical devices through an integrated production system from product planning to development and supply, which translates into high quality competitiveness. Efforts to actively incorporate feedback from medical fields into research and manufacturing processes enhance market trust.Operation of a 100% in-house production system and a rigorous quality control framework. The company adheres to a principle of producing flawless medical devices through an integrated production system from product planning to development and supply, which translates into high quality competitiveness. Efforts to actively incorporate feedback from medical fields into research and manufacturing processes enhance market trust.
- Innovation capabilities driven by continuous R&D investment and adoption of new technologies. Investing over 4% of its revenue in R&D, the company focuses on new product development and existing product improvement. Proactive response to evolving medical paradigms, such as developing dedicated products for bioelectronic medicines and pursuing new ventures in microneedle technology, secures future growth drivers.Innovation capabilities driven by continuous R&D investment and adoption of new technologies. Investing over 4% of its revenue in R&D, the company focuses on new product development and existing product improvement. Proactive response to evolving medical paradigms, such as developing dedicated products for bioelectronic medicines and pursuing new ventures in microneedle technology, secures future growth drivers.
- Target Industrie
- Medical Device IndustryMedical Device Industry
- Surgical Field (especially Laparoscopic Surgery)Surgical Field (especially Laparoscopic Surgery)
- Minimally Invasive Surgery FieldMinimally Invasive Surgery Field
- Robotic Surgery FieldRobotic Surgery Field
- Major Markets
- South Korea (domestic market), India (SKD export, OEM initiatives), Japan (OEM business materializing, exports intensifying)South Korea (domestic market), India (SKD export, OEM initiatives), Japan (OEM business materializing, exports intensifying)
- Europe (CE certification, MDR transition efforts, export market)Europe (CE certification, MDR transition efforts, export market)
- USA (FDA registration and 510K approval, export market)USA (FDA registration and 510K approval, export market)
- Certifications/Patents
- US Food and Drug Administration (FDA) 510K (Class 2) approval (especially for the new model of LAP-iX laparoscopic surgical device)US Food and Drug Administration (FDA) 510K (Class 2) approval (especially for the new model of LAP-iX laparoscopic surgical device)
- Acquisition of European CE certification and ongoing efforts for transition to enhanced European Medical Device Regulation (CE-MDR)Acquisition of European CE certification and ongoing efforts for transition to enhanced European Medical Device Regulation (CE-MDR)
- Recipient of the Minister of Health and Welfare Award and the Korea Health Industry Development Institute Award at the 21st Regular General Meeting Commemorative Awards of the Korea Medical Devices AssociationRecipient of the Minister of Health and Welfare Award and the Korea Health Industry Development Institute Award at the 21st Regular General Meeting Commemorative Awards of the Korea Medical Devices Association
- Recipient of the Korea Health Industry Development Institute Award at the 42nd Regular General Meeting 'Government and Related Organization Awards' (for contributions to localizing laparoscopic surgical instruments)Recipient of the Korea Health Industry Development Institute Award at the 42nd Regular General Meeting 'Government and Related Organization Awards' (for contributions to localizing laparoscopic surgical instruments)
- Recipient of the Minister of Food and Drug Safety Commendation at the 37th Korea International Medical & Hospital Equipment Show (KIMES 2022)Recipient of the Minister of Food and Drug Safety Commendation at the 37th Korea International Medical & Hospital Equipment Show (KIMES 2022)
- Recipient of the Presidential Commendation and Million Dollar Export Tower AwardRecipient of the Presidential Commendation and Million Dollar Export Tower Award
- Proprietary technology development capabilities, including the successful localization of the first domestic laparoscopic trocarProprietary technology development capabilities, including the successful localization of the first domestic laparoscopic trocar
Introduction
Location
11 Sinchon 2-ro, Paju-si, Gyeonggi-do, South Korea
클릭하여 위치 살펴보기
